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1. Introduction
Pyrazoles consist of two nitrogen atoms adjacent to three carbon atoms in a five-
membered aromatic ring structure (Figure 1). Due to the broad spectrum of biological
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Unsubstituted pyrazole can be represented in three tautomeric forms [2] (Figure 2). 
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Interestingly, pyrazoles as a class of azoles, are found in naturally occurring com-
pounds. Kikuchi et al. [3] reported on two compounds, 1-[2-(5-hydroxymethyl-1H-pyr-
role-2-carbaldehyde-1-yl)ethyl]-1H-pyrazole (1) and 1-({[5-(α-D-galactopyranosyloxy)me-
thyl]-1H-pyrrole-2-carbaldehyde-1-yl}-ethyl)-1H-pyrazole (2), which were isolated from 
an extract of watermelon seeds (Figure 3). Pyrazoles also display innumerable chemical, 
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Figure 1. Structure of pyrazole.
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Figure 2. Tautomeric forms of unsubstituted pyrazole.
Interestingly, pyrazoles as a class of azoles, are found in naturally occurring com-
pounds. Kikuchi et al. [3] reported on two compounds, 1-[2-(5-h droxymethyl-1H-pyrrole-
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2-carbaldehyde-1-yl)ethyl]-1H-pyrazole (1) and 1-({[5-(α-D-galactopyranosyloxy)methyl]-
1H-pyrrole-2-carbaldehyde-1-yl}-ethyl)-1H-pyrazole (2), which were isolated from an ex-
tract of watermelon seeds (Figure 3). Pyrazoles also display innumerable chemical, bio-
logical, agrochemical, and pharmacological properties [4]. Moreover, a large number of
structurally diverse natural compounds containing azole nucleus constitute an important
class of biologically active heterocycles that are gaining more attention in the field of
medicinal chemistry [5].
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Figure 3. Structure of isolated pyrazoles of watermelon seeds.
Many pyrazoles have shown luminescent and fluorescent agents. Some of these
compounds have important applications in material chemistry [6] and as brightening
agents [7]. Others exhibit solvatochromic [8] and electroluminescence [9] properties. More-
over, some pyrazoles act as semiconductors [10], liquid crystals [11], and organic light-
emitting diodes [12].
In biological aspects, pyrazoles are known to exhibit antibacterial [13], anticancer [14,15],
anti-tubercular [16], anti-inflammatory [17,18], antidepressant [19,20], antifungal [21], anxi-
olytic [22], anti-AIDS [23], and anti-malarial activities [24]. Pyrazoles also exhibit promising
antioxidant activities [25], analgesic properties [26], they bind to estrogen receptors [27],
they have neuroprotective properties [28], have the capability of binding to the monoamine
oxidase enzyme [29], they have antihepatotoxicity properties [30], antileishmanial prop-
erties [31], antiproliferative properties [32], are preferred for tissue non-specific alkaline
phosphatase inhibitor inhibition [33], act as cyclin-dependent kinase inhibitors [34], have
ant -hyperglycemic p operties [35], anti-nitric oxide synthas (NOSs) [36], have immuno-
uppress nt properties [37], nd demonst ate insecticidal activitie [38].
Pyrazoles are frequently observed as bioactive components in commercially available
medicines. For example, rimonabant is a cannabinoid ligand and is used for treating
obesity; fomepizole prevents alcohol dehydrogenase, celecoxib is a nonsteroidal anti-
inflammatory drug (NSAID), specifically, a COX-2 inhibitor, which relieves pain and
inflammation, and sildenafil is a PDE5 inhibitor used in the treatment of erectile dysfunc-
tion [39] (Figure 4).
This review summarizes the updated methods (until the end of 2020) that are generally
used to prepare substituted pyrazoles and their heteroannulated pyrazoles and sheds light
on their biological activities. Different approaches can be consid red for synth sizing
pyrazoles, such as 2 + 2 + 1, 2 + 3, 4 + 1, 6 − 1, etc. (Scheme 1).
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Figure 4. Drug molecules containing pyrazole scaffolds.
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Scheme 1. The general approach to form pyrazole derivatives.
In addition, these methods can be combined with metal-catalyzed, organo-catalyzed,
flow chemistry, and other methods. In this context, many methods address atom economy
(“green”) and multi-component reactions.
2. Synthesis of Pyrazoles
.1. Cyclocondensation of Hydrazines
2.1.1. Cyclocondensation of Hydrazines with 1,3-Dicarbonyl Compounds
Cyclocondensation of 1,3-dicarbonyl compounds 3 with substituted hydrazines 4
gave the corresponding substituted pyrazoles regioisomers 5 and 5′ (Scheme 2) in different
yield per entages depending on the electronic effects, such as the inductive (el ctron o
withdrawing character) and the s eric factors f both sub titu nts R1 and R3 (R1 and R3
are unequal). For example, if R1 constitutes an aryl group and R3 constitutes an alkyl
substituent, the reaction proceeds, under conventional conditions, to give the regioisomer
5 as the major product, whereas 5′ is formed in traces. The selectivity obtained is of the
order of 98:2 (i.e., R1 = Ar and R3 = CH3) [40].
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Scheme 2. Knorr synthesis of pyrazoles 5 and 5′.
Iodine was used as a halogenated agent that enhances the cyclization process. Starting
with ethyl acetoacetate (6) nd oxamic acid hiohydrazide 7 as model substrates (Scheme 3),
using an equimolar amount of I2 in the presence of 10 mol% f TsOH as an additive,
afforded pyrazole derivative 8 in 83% yield within 48 h [41]. Different trials using other
halogenated agents, such as Br2, NCS, or NBS, were also carried out. Iodine was proven as
the proper one that gave high yields.
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Table 1. Synthesis of 11 under different reaction conditions. 
Entry Catalyst Amount (mol %) Time (min) Yield (%) 
1 ZnO (Bulk) 5 45 50 
2 TiO2 5 40 30 
3 Al2O3 5 45 55 
4 ZnO (nano) 10 15 95 
5 ZnO (nano) 10 25 85 
6 ZnO (nano) 20 15 93 
In 2006, Heller and Natarajan synthesized pyrazoles 5 from the reaction between hy-
drazine and 1,3-diketones (Scheme 6). The diketo compounds 3 were successfully pre-
pared in good yields by lithiation, using lithium bis(trimethylsilyl)amide (LiHMDS), fol-
lowed by subsequent addition of the acid chlorides (Scheme 6) [38]. 
Scheme 3. Synthesis of pyrazole derivative 8.
Ohtsuka et al. [42] prepared 1,3,4,5-tetrasubstituted pyrazole 10 in 63% yield by
the condensation of phenyl hydrazine (4) with the 2-(trifluoromethyl)-1,3-diketone (9) in
refluxing ethanol (Scheme 4) [42].
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Scheme 4. Synthesis of the 1,3,4,5-tetrasubstituted pyrazole 10.
Girish et al. [43] showed an efficient nano-ZnO procedure that catalyzed the prepara-
tion of 3-methyl-1-phenyl-1H-pyrazol-5-ol (11) in excellent yield (95%) during the conden-
sation reaction between ethyl acetoacetate and phenylhydrazine (Scheme 5) [43]. Table 1
summarizes the experimental trials used and the optimal conditions of the chosen catalyst
and its concentrations.
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Table 1. Synthesis of 11 under different reaction conditions.
Entry Catalyst Amount (mol%) Time (min) Yield (%)
1 ZnO (Bulk) 5 45 50
2 TiO2 5 40 30
3 Al2O3 5 45 55
4 ZnO (nano) 10 15 95
5 ZnO (nano) 10 25 85
6 ZnO (nano) 20 15 93
In 2006, Heller and Natarajan synthesized pyrazoles 5 from the reaction between
hydrazine and 1,3-diketones (Scheme 6). The diketo compounds 3 were successfully
prepared in good yields by lithiation, using lithium bis(trimethylsilyl)amide (LiHMDS),
followed by subsequent addition of the acid chlorides (Scheme 6) [38].




Scheme 6. Synthesis of trisubstituted pyrazoles 5. Reagents and conditions; (a) i—2.1 eq LiHMDS, 
Toluene/THF, 0 °C, 1 min, ii—1 eq R3COCl, r.t, 1 min; (b) i—34 eq NH2NH2.H2O, ii—EtOH/THF/Tol-
uene/AcOH (10:7:5:5), reflux 5 min. 
3-Methyl-5-oxo-4-(2-arylhydrazono)-4,5-dihydro-1H-pyrazole-1-carbothioamides 
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shown in Scheme 7. 
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2.1.2. With α,β-Unsaturated Ketones
The regioselectivity of the reaction of various β-aminoenones on different monoalkyl,
acetyl-, methoxycarbonylhydrazine, and semicarbazide was studied by Alberola et al. [45].
y found that the smallest bulky group, when attached at th β-positi of th none,
obtained high regioselectivity from the reaction of β-aminoenones 16a–c, which possessed
the least bulky substituent (CH3) in the β-position with alkyl hydrazines 4, in DMSO. Subse-
quently, pyrazoles 5a–c and 5′a–c were obtained with high regioselectivity (Scheme 8) [45].
When different β-aminoenones 16a–c with bulkier β-substituents were used, the reactivity
towards produc formation decreas d, but more important than this decrease in reactivity
was the drop in regioselectivity. This phenomenon was greater when R1 and the alkyl
hydrazine were bulkier [45]. Compounds 5a–c were formed in yield percentages from
78–97% compared with their regioisomers 5′a–c [45].
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Scheme 10. Synthesis of 3,5-diphenyl-1H-pyrazole 5.
Rao et al. [48] described a method to prepare pyrazole derivative 5 via condensation
of a ch lcone 22 with p-((t-butyl)p enyl)hydrazine 4 in the presence of copper triflate
and 1-butyl-3-methylimidazolium hexafluorophosphate [BMIM-PF6] 23 as a catalyst. The
reaction proceeded via the formation of compound 24 (Scheme 11) [48]. Further opti-
mization of the reaction conditions was carried out by changing solvents, catalysts, and
catalyst loading. The use of 20 mol% Cu(OTf)2 in 23 gave the desired product 5 in excellent
yield (82%). When Cu(OTf)2 as replace with other catalysts, such as p-TSA, Sc(OTf)3,
Ce(OTf)3, Zn(OTf)2, AgOTf, or Yb(OTf)3, a mixture of 24 and 5 was observed. The use of
Ce(OTf)3 in 23 res lted in a 75% yield of 24 along wit 10% of 5, whereas the use of p-TSA
in 23 gave 69% of 24. The obtained data indicate that Cu(OTf)2 was involved in the aerobic
oxidation of 4 to 5. It is ecessary to mention that 5 was not formed in the absence of
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Scheme 11. esis of 1,3,5-trisubstituted pyrazole 5.
Bonacorso et al. [49] synthesized a series of 3-aryl(alkyl)-5-triflfluoromethyl-1H-pyrazoles
27a–g from the reaction of 4-alkoxy-4-aryl(alkyl)-1,1,1-triflfluoro-3-buten-2-ones 25 with
thiosemicarbazide (14). The reaction gave the corresponding 5-hydroxy-5-triflfluoromethyl-
1-pyrazole thiocarboxamides 26. Subsequently, dehydration and removal of the thiocar-
boxya ide group with sulfuric acid 96% produced the desired products 27a–g in 57–75%
yields (Scheme 12) [49]. It was concluded that the presence of the thiocarboxyami e group
on position 1 of the pyrazolines 26 acts as a protective group with an electron-withdrawing
effect, hindering the elimination of water and the subsequent aromatization of the five-
membered ring. The presence of a trifluoromethyl group on the vinyl ketones 25 and
the thiocarboxyamide group on the dinucleophile (thiosemicarbazide) was the determin-
ing factor of the regiochemistry of the reaction. Moreover, the presence of α-alkyl- and
β-alkyl[aryl]-substituent on the vinyl ketones 25 did not show observable effects on the
regiochemistry of the reaction.
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(14), CH3OH; (b) r.t. to 45 ◦C, 20–24 h; (c) H2SO4 96%, reflux, 4 h.
Synthesis of pyrazoles substituted by thiophene moiety 29 could be carried during the
reaction of chalc ne-t pe c mpound 28 with phenyl hydrazine hydrochloride 4-HCl via
3 + 2 annulati ns (Scheme 13). The obtained thiophene-pyrazole hybrids 29 were screened
as antimicrobial and antioxidant agents (Scheme 13) [50].
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Harigae et al. [54] reported on the synthesis of 3,5-disubstituted pyrazole 5 with
high regioselectivity in a one pot procedure via the reaction of phenylacetylene (20) with
aromatic aldeh des 34, molecula iodine, and hydrazines 4 (Schem 17) [54]. The mech-
anism explains the formation of acyl phenylacetylene 38 due to the lithiation process
that generates an acetylenic nucleophilic site and attacks the aldehydic carbonyl to form
the intermediate 39 (Scheme 17). Subsequently, the formed nucleophilic center would at-
tack to the iodine molecule to form the intermediate 40, which executes HI to form 38
(Scheme 17) [54]. The formed intermediate 38 with substituted hydrazines would give
compounds 5 accompanied by the elimination of H2O (Scheme 17).
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tuted pyrazoles 43 from phenylhydrazones 41 and dialkyl acetylenedicarboxylates 42 
(Scheme 19). Table 2 summarizes the reaction conditions from the molar ratios of the cat-
alyst and base. Moreover, the reaction yields the products in the absence of a catalyst and 
case of nitrogen atmosphere. The best condition was equal equivalents of the starting sub-
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Ji et al. [55] reported on an efficient procedure for synthesizing 3-trifluoromethylpyrazole
5 in 60% yield via trifluoromethylation/cyclization of acetylenic ketones 38 with phenyl-
hydrazine (4) using (1-trifluoromethyl-1,2-benziodoxol-3(1H)-one) (Togni reagent)
(Scheme 18) [55].
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Scheme 19. Synthesis of polysubstituted pyrazoles 43 (41 (0.2 mmol), 42 (0.2 mmol), base (0.2 mmol),
catalysts (0.02 mmol) in 2 mL of solvent for 2 h under air).
Table 2. Synthesis of 43 under different reaction conditions.
Entry Catalyst Base Solvent Yield (%) a
1 CuI NaOAc DME 73
2 b CuI NaOAc DME 44
3 CuI - DME trace
4 c CuI NaOAc DME 75
5 d CuI NaOAc DME 75
6 - NaOAc DME 0
a Isolated yield. b Reaction was carried out with 0.2 equiv. of base. c Reaction was carried out with 2 equiv. of
base. d Reaction was carried out with 1.0 equiv. of base under nitrogen.
Martín et al. [57] reported a facile method in preparing pyrazoles 5 via Cu-catalyzed
domino C-N coupling hydroamination reaction (Scheme 20). The procedure involving the
reaction of acetylenes 44 and diamine 45 in the presence of copper (I) iodide and N1,N2-
dimethylethan-1,2-diamine (46) under reflux of THF at 80 ◦C to give 47 and then pyrazoles
5 were formed in 66–93% yields (Scheme 20) [57].
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In 2011, Jackowski et al. showed heterocycles 50 could be obtained by a simple
metalation cyclization process (Scheme 21).
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1H-pyrazole-3,4-dicarbonitrile (56) from the reaction 2-quinolonyl hydrazine 54 with 
1,1,2,2-ethenetetracarbonitrile (55) (Scheme 23). Compound 56 was evaluated as good an-
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Gentle heating at 50 °C of equimolar solutions of N-phenylhydrazinecarbothioamide 
(57) and 2-bis(methylthio)methylene)malononitrile (58) in absolute ethanol containing 0.5 
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Aly and his co-workers also investigated the antioxidant activity, anti-apoptotic ac-
tivity, and caspase-3 inhibition of pyrazoloquinolinones 61a–f as described in Scheme 25. 
Formation of 61a–f was established via the reaction of 2-quinoloyl-4-hydrazines 54a–f 
with ethyl 2-cyano-3,3-bis(methylthio)acrylate (60) (Scheme 25). Compound 61c was the 
most potent against inflammation, whereas 61d showed the most active caspase-3 [61]. 
Scheme 22. MW assisted synthesis of pyrazoles 53. Reagents and conditions. Method (I) EtOH/Et3N, reflux 10–16 h
(10–25%). Method (II) MW (75–87%).
In addition, Aly et al. prepared 5-amino-1-(1-ethyl-2-oxo-1,2-dihydroquinolin-4-yl)-
1H-pyrazole-3,4-dicarbonitrile (56) from the reaction 2-quinolonyl hydrazine 54 with 1,1,2,2-
eth netetracarbonitrile (55) (Scheme 23). Compound 56 was evaluated as good antiprolifer-
ative EGFR-TK inhibitors against many tumor cell lines (Scheme 23) [60].
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In 2017, Aly et al. showed that amidrazones 51 reacted with ethyl 2-cyano-3-ethoxy-
but-2-enoate (62) in refluxing absolute EtOH containing triethylamine (Et3N), compounds 
63 (70–85%) were obtained, after chromatographic purification and recrystallization 
(Scheme 26) [62]. 
 
Scheme 26. Synthesis of pyrazoles 63. 
1-Aryl-4-(4,5-dihydro-1H-imidazol-2-yl)-3-methyl-1H-pyrazoles 67 were obtained in 
three steps as outlined in Scheme 27. 
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Compounds 67, which were obtained in 50–85% yields (Scheme 27), showed good 
antithrombotic activity in a murine model of arterial thrombosis [63]. 
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inhibition.
In 2017, Aly et al. showed that amidrazones 51 reacted with ethyl 2-cyano-3-ethoxybut-
2-enoate (62) in refluxing absolute EtOH containing triethylamine (Et3N), compounds 63
(70–85%) were obtained, after chromatographic purification and recrystallization
(Scheme 26) [62].
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Compounds 67, which were obtained in 50–85% yields (Scheme 27), showed good
antithrombotic activity in a murine model of arterial thrombosis [63].
Synthesis of pyrazole derivatives 69a–c bearing imidazo[4,5-b]indole moiety was
achieved by the reaction of ylidenes 68a–c with hydrazine hydrate (Scheme 28). The
obtained products were successfully examined for their antibacterial activities against four
bacterial strains (Bacillus subtilis, Staphylococcus aureus, Escherichia coli, and Pseudomonas
aeruginosa) and antifungal activities against two fungi (Aspergillus flavus and Candida
albicans) [64].
N-Tosyl hydrazones 70 with unactivated bromovinyl acetals 71 via 1,3-dipolar cy-
cloaddition reaction to give 3,5-disubstituted 72 pyrazoles was obtained in yields of up to
92% (Scheme 29) [65].
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Scheme 32. Synthesis of pyrazole-4-carbaldehyde derivatives 74.
A series of pyrazole derived by thiophene derivatives 76 was achieved. As 1,3-
disubstituted-1H-pyrazole-4-carbaldehydes 74 were synthesized by Vilsmeier–Haack re-
action of hydrazones 73 (Scheme 33). Subsequently, a reaction of 74 with 2-amino-5-(2,4-
dichlorophenyl)thiophene-3-carbonitrile (75) in the presence of a catalytic amount of glacial
acetic acid in ethanol provided 76 in good yields (Scheme 33) [69]. The obtained products
were then evaluated for their antibacterial, anti-inflammatory, and antitubercular studies.
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Scheme 33. Pyrazole-clubbed thiophene derivatives 76.
Pyrazole-4-carbaldehyde sulfonate derivatives 74a–f were synthesized via Vilsmeier–
Haack reaction hydrazone of sulfonic acids 73a–f with acetophenones. Treatment of
compounds 74a–f with thiazolidine-2,4-dione gave the corresponding condensed products
77a–f (Scheme 34) [70].
Compounds 77a–f were evaluated for their COX inhibition, AI activity, ulcerogenic
liability, and anti-diabetic activity. The target compounds were assessed in vitro against
α-glucosidase and β-glucosidase, in vivo hypoglycemic activity in addition to PPARγ
activation study. Two derivatives gave higher COX-2 S.I. (8.69–9.26) than the COX-2 se-
lective drug celecoxib (COX-2 S.I. = 8.60) and showed the highest AI activities and the
lowest ulcerogenic than other derivatives. Moreover, these derivatives showed higher
inhibitory activities against α- and β-glucosidase (% inhibitory activity = 62.15 and 55.30 for
α-glucosidase and 57.42 and 60.07 for β-glucosidase) than reference compounds (acarbose
with % inhibitory activity = 49.50 for α-glucosidase and D-saccharic acid 1,4-lactone mono-
hydrate with % inhibitory activity = 53.42 for β-glucosidase) and also showed good PPAR-γ
activation and good hypoglycemic effect in comparison to pioglitazone and rosiglitazone.
Similarly, two sets of trisubstituted pyrazole derivatives 78a–e and 79a–e were syn-
thesized by the steps shown in Scheme 35. The obtained products were evaluated for
their anti-inflammatory effects, cyclooxygenase (COX) inhibitory activity, and ulcerogenic
liability (Scheme 35) [71]. Some derivatives of compounds 78a–e and 79a–e showed consid-
erable edema inhibition percentage range compared with celecoxib (13–93% and 58–93%,
respectively) at different time intervals. Compound 79e showed the best screening results if
compared with celecoxib (inhibition % = 93.62 and 93.51% at 5 h, COX-1/COX-2 selectivity
index SI = 215.44 and 308.16, and ulcer index = 7.25 and 8, respectively).
2.2. Pyrazoles from Diazo Compounds
Diazoalkanes served as starting materials for the classical Pechmann reaction. Ag-
garwal et al. reported a one-pot approach proposed using diazo compounds 81 gener-
ated in situ from tosyl hydrazone salts 80 (Scheme 36). Direct 1,3-cycloaddition of diazo
compounds 81 would afford the pyrazole 5 after an aromatization of the cycloadduct
intermediate 82 (Scheme 36) [72].
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Scheme 34. Synthesis of pyrazole sulfonate derivatives 77a–f.
1,3,4,5-Tetrasubstituted pyrazoles 85 were synthesized in moderate to good yields
through the one-pot reaction of the Huisgen zwitterion from triphenylphosphine in
dimethoxyethane (DME) and dialkyl azodicarboxylates 83 with 3-substituted allenoates 84
(Scheme 37) [73].
In 2006, Hari et al. [74] synthesized di- and trisubstituted pyrazoles 89 by the reaction
of (diazomethyl)trimethylsilane (86) with MgBr2 and ketones to give 87, which subse-
quently reacted with ethyl propiolate (88) or dimethyl acetylenedicarboxylate (42) under
reflux of THF to give pyrazoles 89 (Scheme 38) [74].
Cross-coupling/electrocyclization reaction of substituted acyclic and cyclic enol tri-
flates 90 with diazoacetates 91 provided the corresponding 3,4,5-trisubstituted pyrazoles
93 [75]. The reaction of 90 with 91 in the presence of N-methylmorpholine (NMM,
Scheme 39) was established via the formation of intermediate 92 (Scheme 39) [75].
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Scheme 39. Synthesis of pyrazole derivatives 93. Reagents and conditions; (a) 5 mol% Pd(PPh3)4; (b) 2 eq. NMM. DMF, r.t.,
3–6 h; (c) 60 ◦C, 12–18 h.
Parham et al. [76] developed a facile reaction of (Z)-(2-nitroprop-1-en-1-yl)benzene 94
with diazomethane to give pyrazoline 95 that lose the nitro group as oxides of nitrogen on
heating, or with acids or bases, to give 3-methyl-4-phenyl-1H-pyrazole 5 (Scheme 40) [76].
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Julia et al. [79] reported on the synthesis of 1,3,4,5-tetrasubstituted pyrazoles 5 (Scheme 43)
via the reaction 100 with various substituted nitriles 101 in the presence of cupper acetate
at 110–120 ◦C (Scheme 43) [79].
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2.3. Heterocyclic Ring Rearrangement
Rai et al. [80] reported on the synthesis of nitrofuran containing 1,3,4,5-tetrasubstituted
pyrazole derivatives 104 (Scheme 44). Compounds 104 were obtained by refluxing 3-(5-
nitrofuran-2-yl)-1-phenylprop-2-yn-1-ones 102 with 4-bromo-3-(aryl)-4,5-dihydro-1,2,3-
oxadiazol-3-ium-5-olates 103 in xylene. Compound 2-(5-bromo-3-(5-nitrofuran-2-yl)-1-
(p-tolyl)-1H-pyrazol-4-yl)-1-(4-bromophenyl)-ethan-1-one (Scheme 44) showed highest
antibacterial and antifungal activity than all other compounds [80].
Chen et al. conducted the synthesis of a trisubstituted pyrazole 105, in 41–48% yields,
via 1,3-dipolar cycloaddition reaction between arylsydnones 103 and α,β-unsaturated
ketones 22 in dry xylene (Scheme 45) [81].
Delaunay et al. [82] described the synthesis of the two regioisomeric 1,3,4,5-substituted
pyrazoles 107 and 108 by a cycloaddition reaction of a 4-iodo-3-(4-methoxy phenyl)-1,2,3-
oxadiazol-3-ium-5-olate 103 with ethyl bromopropiolate (106). The separation of pyrazoles
107 and 108 was easily performed by silica gel chromatography (Scheme 46) [82].
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Xie et al. [84] have developed an efficient protocol to prepare 3,4-diarylpyrazoles
5 in 48–95% yields [84]. The strategy involves sequential Suzuki coupling between
iodochromones 111 and phenylboronic acids 112 in the presence of Pd(PPh3)4 and K2CO3,
followed b condensation with hydrazine hydrate (Scheme 48) [84].
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Rykowski et al. [85] prepared pyrazoles from triazines by condensation of 3-chloro-
6-phenyl-1,2,4-triazines 113 on α-chlorosulfonyls in the presence of KOH and DMSO as a
solvent to give the corresponding pyrazoles 114 in 47–93% yields (Scheme 49) [85].
In 2000, Simoni et al. [86] reported that tetrazolyl acroleins 115 reacted with fumaroni-
trile (116) in xylene at 140 ◦C t give the correspondi g pyrazoles 117 (Scheme 50) [86].
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PdCl2(PPh3)2/CuI. Reagents and conditions; (a) PdCl2(PPh3)2/CuI, Et3N, THF/CH3CN, rt 2 h, THF;
(b) NH2NH2/CH3CN.
The four-component reaction of aromatic aldehydes 34, malononitrile, phenylhy-
drazine (4), and ethyl acetoacetate (6) in the presence of sodium benzoate in an aqueous
solution (Scheme 52) was reported to give compounds 118 [88]. Sodium benzoate was used
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as the mild basic catalyst. Table 3 summarizes the trials using different molar % of catalysts
and the corresponding yields of products [88].
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(Scheme 54) [90].
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2.5. Eco-Friendly Methods for Pyrazole Synthesis
Beyzaei et al. [91] synthesized polysubstituted pyrazoles 65 in 84–91% yields through a
two-step, one-pot procedure. In this technique, the reaction of 2,4-dinitrophenylhydrazine,
malononitrile, and different aldehydes 34 in deep eutectic solvent (DES) were carried out
(Scheme 55) [91].
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Four-component one-pot preparation of 1,4-dihydropyrano[2,3-c]pyrazoles 118 us-
ing phenylhydrazine 4 or hydrazine monohydrate, acetoacetic ester (6), malononitrile, 
and aldehydes 34 under thermal and solvent-less conditions with maltose as a catalyst 
was reported by Kangani et al. The reaction efficiently proceeded to produce the respec-
tive products 118 in 74–89% yields (Scheme 56) [92]. 
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Zolfigol et al. described an effective three-component condensation reaction of malo-
nonitrile, aryl aldehydes, and phenyl hydrazine (4) under solvent-free conditions using 1-
methylimidazolium trinitromethanide {[HMIM]C(NO2)3} (119) as a catalyst in the for-
mation of 5-aminopyrazole-4-carbonitriles 65 (Scheme 57) [93]. 
 
Scheme 57. Synthesis of polysubstituted pyrazoles 65. 
Under microwave irradiation, the reaction of 1,3-diketones 3 with phenylhydrazine 
(4) in the presence of organic nanocatalyst in an aqueous medium produced pyrazoles 5 
in 78–98% yields (Scheme 58) [94]. 
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products 118 in 74–89% yields (Scheme 56) [92].
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Under microwave irradiation, the reaction of 1,3-diketones 3 with phenylhydrazine
(4) in the presence of organic nanocatalyst in an aqueous medium produced pyrazoles 5 in
78–98% yields (Scheme 58) [94].
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200 W, 100 ◦C, 3–6 min.
A grinding induced the formation of highly substituted pyrazoles 65 by applying
malononitrile, functionalized aldehydes 34, and phenylhydrazine (4). Singh et al. reported
this procedure utilizing IL 121 as a catalyst without the formation of any byproducts
(Scheme 60). Most importantly, simple handling and attainment of high yield up to 97%
are the advantages of this methodology [96].
Molecules 2021, 26, 4995 27 of 71




Scheme 58. Synthesis of pyrazoles 5. 
Facile formation of functionalized pyrazole derivatives 120 under solvent-less condi-
tions was achieved by treating 4 with aldehydes 34 and acetoacetic ester (6). This method-
ology showed the synthetic potential of microwave irradiation and scandium (III) triflate 
Sc(OTf)3 as a catalyst (Scheme 59) [95]. 
 
Scheme 59. Synthesis of polysubstituted pyrazoles 120. Reagents and conditions; (a) Sc(OTf)3, MW 
200 W, 100 °C, 3–6 min. 
A grinding induced the formation of highly substituted pyrazoles 65 by applying 
malononitrile, functionalized aldehydes 34, and phenylhydrazine (4). Singh et al. reported 
this procedure utilizing IL 121 as a catalyst without the formation of any byproducts 
(Scheme 60). Most importantly, simple handling and attainment of high yield up to 97% 
are the advantages of this methodology [96]. 
 
Scheme 60. IL mediated formation of highly substituted pyrazoles 65. 
  
Scheme 60. IL mediated formation of highly substituted pyrazoles 65.
3. Heteroannulated Pyrazoles
3.1. Heteroannulation with Six-Membered Heterocycles
3.1.1. Pyranopyrazoles
Pyranopyrazoles consists of four possible isomeric forms naming as pyrano[2,3-
c]pyrazole, pyrano[4,3-c]pyrazole, pyrano[3,2-c]pyrazole, pyrano[3,4-c]pyrazole and
pyrano[2,3-c]pyrazole, are found as the most widely studied (Figure 5).
Molecules 2021, 26, x FOR PEER REVIEW 25 of 64 
 
 
3. Heteroannulated Pyrazoles 
3.1. Heteroannulation with Six-Membered Heterocycles 
3.1.1. Pyranopyrazoles 
Pyranopyrazoles consists of four possible isomeric forms naming as pyrano[2,3-c]py-
razole, pyrano[4,3-c]pyrazole, pyrano[3,2-c]pyrazole, pyrano[3,4-c]pyrazole and py-
rano[2,3-c]pyrazole, a e found as th  most widely studie  (Figur  5). 
 
Figure 5. Isomeric structure of pyranopyrazoles. 
4-Benzylide-pyrazol-5-one 122 with malononitrile in methanol in the presence of so-
dium acetate catalyst has been used to obtain pyrano[2,3-c]pyrazoles 118 (Scheme 61) [97]. 
 
Scheme 61. Formation of pyrano[2,3-c]pyrazoles 118. 
Peng and co-workers reacted 5-alkoxycarbonyl-2-amino-4-aryl-3-cyano-6-methyl-
4H-pyrans 123 with hydrazine hydrate in the presence of a catalytic quantity of pipera-
zine, and the corresponding pyranopyrazoles 118 were obtained (Scheme 62). The strat-
egy of the synthesis was carried out in three methods, namely (i) heating; (ii) exposure to 
microwave irradiation; (iii) exposure to a combination of microwave and ultrasound irra-
diation (CMUI). The procedure was later found to be excellent in yield within a short time 
(Scheme 62) [98]. 
 
Scheme 62. Formation of pyrano[2,3-c]pyrazole 118. 
Dyachenko and Rusanov allowed stirring benzylidene-pyrazolone 122 with cy-
anothioacetamide in morpholine containing an ethanolic solution to obtain various py-
ranopyrazoles 118 (Scheme 63) [99]. 
Figure 5. Isomeric structure of pyranopyrazoles.
4-Benzylide-pyrazol-5-one 122 with malononitrile in methanol in the presence of
sodium acetat catalyst has been used to obtain pyrano[2,3-c]pyrazoles 118 (Scheme 61) [97].
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Scheme 61. Formation of pyrano[2,3-c]pyrazoles 118.
Peng and co-workers reacted 5-alkoxycarbonyl-2-amino-4-aryl-3-cyano-6-methyl-4H-
pyrans 123 with hydrazine hydrate in the presence of a catalytic quantity of piperazine,
and the corresponding pyranopyrazoles 118 were obtained (Scheme 62). The strategy
of the synthesis was carried out in three methods, namely (i) heating; (ii) exposure to
microwave ir adiatio ; (iii) exposure to c mbination of microwave and ultrasound
irradiatio (CMUI). The procedure was later found to be excellent in yield within a short
time (Scheme 62) [98].
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Scheme 64. Formation of 3-aminopyrano[2,3-c]pyrazoles 126.
Hafez and co-workers reacted 2-oxo-3-substituted indole 127 with pyrazolone 128 in boil-
ing ethanol and catalyzed by Et3N to prepare spiropyranylindolones 129 (Scheme 65) [101].
Pyranopyrazoles 118 were obtained in good yields by a three-component reaction of
aldehydes 34, malono itrile, and pyrazol-5-one 128, in efluxing ethanol with piperi ine
catalyst (Scheme 66) [102].
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Pyrano[2,3-c]pyrazoles 118 were prepared by a four-component reaction of aldehydes
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various catalysts, solve ts, temperatures, and green techniques, which were also applied
(Scheme 67) [103].
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Scheme 67. Synthesis of pyranopyrazoles 118.
Enders and co-workers prepared the enantioselective tetrahydropyrano-pyrazoles 131
from the reaction of pyrazolone 128, α,β-unsaturated aldehydes, and Wittig reagent 130 in
the presence of secondary amines, such as catalysts (Scheme 68) [104].
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Lu and co-workers reported on a one-pot synthesis of pyranopyrazoles 118 via Suzuki
coupling between 4-bromobenzaldehyde and aryl boronic acid 132 together with KF·2H2O
as a dehalogenating agent in the presence of Pd/C at 80 ◦C. Firstly, 4-bromobenzaldehyde
and aryl boronic acid was adde to form substituted biphenyl aldehydes; subs quently,
other reagents were added and allowed to react for 5–6 h (Scheme 69) [105].
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used as a selective phosphodiesterase 5 (PDE5) to treat male erectile dysfunction as an 
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was prepared, and the in vitro PDE5 inhibitory activities were evaluated; the results re-
vealed improved activity and selectivity [107]. 
Scheme 69. Multicomponent synthesis of pyrano-pyrazoles 118. Reagents and condition: (a) Pd/C, DMF, 1 mol% Pd;
(b) 50% DMF, KF·2H2O, 80 ◦C.
Another five components, synthesis of pyranopyrazoles 118, involved a mixture of
acid chlorides, Meldrum’s acid (133), aromatic aldehydes 34, hydrazine hydrate, and
malononitrile in the presence of CuI nanoparticles (Scheme 70) [106].
3.1.2. Pyrazolopyrimidi e
Pyrazolopyrimidines are considered the structural analogs of the biogenic purine class.
Pyrazolopyrimidines are of interest as potential bioactive molecules. Pyrazolopyrimidines
have four known structures, as illustrated in Figure 6.
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Figure 6. Isomeric forms of pyrazolopyrimidines.
One of the essential pharmacological applications of pyrazolo[4,3-d]pyrimidine deriva-
tives is Sildenafil (Viagra®®, 134) and its analogs 135 (Figure 7). Compounds 135 were
used as a selective phosphodiesterase 5 (PDE5) to treat male erectile dysfunction as an oral
agent. Recently, a series of Sildenafil analogs (R = Me, Et; R2 = Me, Et, -CH2CH2OH) was
prepared, and the in vitro PDE5 inhibitory activities were evaluated; the results revealed
improved activit and sel ctivity [107].




Figure 7. Chemical structure of Sildenafil 134 and Sildenafil analog 135. 
The reaction of compound 136 with benzoyl isocyanate in the presence of ammonium 
hydroxide gave 5-amino-1-phenylpyrazolo[3,4-d]pyrimidinone derivative (137) (Scheme 
71) [108]. Treatment of 136 with triethyl orthoformate in acetic anhydride afforded the 
methanimidate 138, which on treatment with ammonia gave pyrazolo[3,4-d]pyrimidin-4-
ylaminederivative 139 (Scheme 71) [109]. 
 
Scheme 71. Synthesis of pyrazolopyrimidinone derivatives 137 and 139. 
5-Amino-1H-pyrazolo[3,4-d]pyrimidine derivative 140 could be obtained directly by 
treatment of 5-aminopyrazole-4-carbonitrile (65) formamidine in acetic acid (Scheme 72) 
[110]. 
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Figure 7. Chemical structure of Sildenafil 134 and Sildenafil analog 135.
The reaction of compound 136 with benzoyl isocyanate in the presence of ammo-
nium ydroxide gave 5-amino-1-phenylpyrazolo[3,4-d]pyrimidino e d rivative (137)
(Scheme 71) [108]. Treatment of 136 with triethyl orthoformate in acetic anhydride afforded
the methanimidate 138, which on treatment with ammonia gave pyrazolo[3,4-d]pyrimidin-
4-ylaminederivative 139 (Scheme 71) [109].
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Scheme 72. Synthesis of 5-Amino-1H-pyrazolo[3,4-d]pyrimidine derivative 140.
The reaction of 5-amino-1-methyl-1H-pyrazole-3,4-dicarbonitrile 141 with N-
methylformamide gave the imine intermediate 142. The latter intermediate underwent ring
opening by a typical Dimroth rearrangement and recyclized to furnish the pyrazolo[3,4-
d]pyrimidine 143 carrying a methylamino group at 4-position (Scheme 73) [111].
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5-Benzamido-1H-pyrazolo[3,4-d]pyrimidin-4-one (147) was prepared by reacting 5-
amino-1H-pyrazole-4(N-benzoyl)carbohydrazide (146) with triethyl orthoformate (TEOF)
(Scheme 75) [113].
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Similarly, reaction of 5-amino-1-phenyl-1H-pyrazole-4-carboxylic acid hydrazide
(148) with urea in decalin gave pyrazolo[3,4-d]pyrimidine-4,6-dione derivative 149
(Scheme 76) [114].
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El-Enany et al. [115] reacted 5-amino-3-methylsulphanyl-1-phenyl-1H-pyrazole- 4-
carboxylic acid amide (150) with propionic anhydride, chloroacetyl chloride or 3-
chloropropionyl chloride to produce the 6-substituted pyrazolo[3,4-d]pyrimidin-4(5H)-one
derivatives 151a–c in 83–96% yield (Scheme 77) [115].
Kandeel et al. [116] synthesized pyrazolo[3,4-d]pyrimidin-4(5H)-one 152 via the
reaction of 5-amino-3-methyl-1H-phenylpyrazole-4-carbonitrile 65 with formic acid
(Scheme 78) [116].
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When pyrazolylcarbothiohydrazide 155 was treated with formic acid or triethyl or-
thoformate, it gave 3-methylsulfanyl-1-(1,3,4-thiadiazolyl-2-yl)pyrazolo[3,4-d]pyrimidin-
4(5H)-one 156 (Scheme 80) [118].
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Ghorab et al. [114] reacted ethyl 5-amino-1-phenyl-1H-pyrazole-4-carboxylate (157)
with hydrazine hydrate or benzyl amine in the presence of triethyl orthoformate (TEOF) to
obtain the 5-substituted derivatives 158a,b (Scheme 81) [114].
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3.1.3. Pyrazolopyridines 
The pyrazolo[3,4-b]pyridine moiety is known as a privileged structural motif of drug-
like molecules. Tracazolate 163, etazolate 164, and glicaramide 165 are considered as drug-
analogous containing pyrazolo[3,4-b]pyridine (Figure 8) [121–123]. 
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Fusion of 159 with formamide at 200 ◦C for 8 h afforded the corresponding pyrazolo[3,4-
d]pyrimidin-4-one 160 (Scheme 82) [119].
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5-Amino-1H-pyrazol-4-carbonitrile derivative 65 afforded with carbon disulfide in
pyridine 4,6-dithioxopyrazolo[3,4-d]pyrimidine derivative 162 upon gentle refluxing. The
reaction underwent a rearrangement process of the thiazine intermediate 161 during
treatment with NaOH (Scheme 83) [120].
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3.1.3. Pyrazolopyridines
The pyrazolo[3,4-b]pyridine moiety is known as a privileged structural motif of drug-
like molecules. Tracazolate 163, etazolate 164, and glicaramide 165 are considered as
drug-analogous containing pyrazolo[3,4-b]pyridine (Figure 8) [121–123].
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Scheme 84. Synthesis of pyrazolo[3,4-b]pyridines 168.
One-pot synthesis of fully substituted 1H-pyrazolo[3,4-b]pyridines 169 was established
based on a three-component approach between 5-aminopyrazoles 166, β-ketonitriles, and
aromatic/aliphatic aldehydes 34 in the presence of triethylamine (Scheme 85) [125].
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Lee and Park [126] reported on the synthesis of aryl pyrazolo[3,4-b]pyridines 171 from
5-aminopyrazoles 166 and indole-3-carboxaldehydes 170 catalyzed by AlCl3 by the indole
ring-opening without using catalysis with transition metals (Scheme 86) [126].
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In 2017, Portilla and co-workers [127] reported on the synthesis of substituted
pyrazolo[3,4-b]pyridines 173 under microwave-assisted regioselective reaction to 5-
aminopyrazoles 166 with 3-(3-oxo-2-benzofuran-1(3H)-ylidene)pentane-2,4-dione 172.
The reaction wa based on a do ino aza-Michael-cyclization-d hydration sequence
(Scheme 87) [127].
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An efficient facile synthesis of substituted pyrazolo[3,4-b]pyridines 175 in 53–86%
yield was reported by Miliutina and co-workers [128]. The protocol was achieved by the
reaction of 5-aminopyrazoles 166 with 3-chlorochromones 174 in the presence of phosphoric
acid (Scheme 88) [128].
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3.2.2. Thienopyrazoles 
There are three different regioisomers of thienopyrazoles, as shown in Figure 9. 
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5-Aminopyrazole 166 was reacted with either ethyl α-chloroacetoacetate or chloroacetyl
chloride to yielded 1-(2-hydroxy-3H-imidazo[1,2-b]pyrazole-3-yl)ethanone 188 and 3H-
imidazo[1,2-b]pyrazole-2-ol 189, respectively (Scheme 94) [134].
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nitro-3-methyl-1-phenylthieno[2,3-c]pyrazole 193 (Scheme 96) [136]. 
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5-Chloro-3-methyl (or phenyl)-1-phenyl-1H-pyrazole-4-carbaldehyde 194a,b reacted 
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4-Bromo-3-methyl-1-phenyl-2-pyrazolin-5-one (197) reacted with ethyl 3-mercapto-
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(Scheme 98) [138]. 
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Figure 9. Regioisomers of thienopyrazoles.
4,5-Dihydro-3-methyl-1-phenyl-5-thioxo-1H-pyrazole-4-carboxaldehyde 192 reacted
with nitromethane in the presence of dibenzoyl peroxide, Et3N in ethanol to produce
5-nitro-3-methyl-1-phenylthieno[2,3-c]pyrazole 193 (Scheme 96) [136].
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1-Phenyl-3-(pyridin-3-yl)-1H-thieno[2,3-c]pyrazole-5-carboxylic acid ethyl ester (200)
was synthesized by the reaction of 5-chloro-1-phenyl-3-(pyridin-3-yl)-1H- pyrazole-4-
carbaldehyde 194 with ethyl bromoacetat and sodium sulfide. First, reaction of 2-phenyl-
5-pyridin-3-yl-2,4-dihydro-pyrazol-3-one (128) with Vilsmeier–Haack reagent gave 194 in
55% yield (Scheme 99) [139].
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A practical and straightforward synthesis of 1-methyl-1H-thieno[2,3-c]pyrazoles from
3-amino-1H-pyrazole-4-carboxylic ci ethyl ester were reported by Toto et al. The 3-
substituted ethyl pyrazole-5-sulfonylacetate derivatives 202a–c were synthesized by the re-
action of 3-substituted ethyl 5-bromo-N-methyl-pyrazole-4-carboxylates 201a–c with ethyl
bromoacetate and sodium sulfide in DMF. Base-catalyzed cyclization of the S-alkylated
pyrazoles 202a,b was accomplished using sodium ethoxide in toluene to afford the ex-
pected ethyl 4-hydroxythieno[2,3-c]pyrazole-5-carboxylate derivatives 203a,b. More ver,
c clization of the amine analog 202c under the same conditions yielded the imin d riva-
tive 204, which probably came from the self-condensation of the expected amino-thieno
fused compound 202c (Scheme 100) [140].
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Scheme 100. Synthesis of thieno[2,3-c]pyrazoles 203a,b and 204.
Using the Sonogashira coupling method and starting with pyrazole derivatives to syn-
thesize thieno[2,3-c]pyrazole was reported by Eller et al. [141]. The strategy depends upon
the treatment of the available 1,3-disubstituted-5-chloro-1H-pyrazoles 205a,b with I2–HIO3
to obtain the corresponding 5-chloro-4-iodopyrazoles 206a,b. The latter compounds were
selectively connect d to phenylacetylen (20) by a Sonogashira ross-coupling reaction,
yielding only the 4-(phenylethynyl)pyrazoles 207a,b in good yields (87–92%). The final
Molecules 2021, 26, 4995 43 of 71
reaction step, compounds 207a,b, was then subjected to sodium sulfide in DMF to produce
compounds 208a,b (Scheme 101) [141].
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Scheme 101. Sonogashira coupling method to synthesize thieno[2,3-c]pyrazoles 208a,b.
Sabaa et al. and Rabie et al. [142,143] have synthesized thieno[2,3-c]pyrazole 209
using the Gewald reaction. The N-phenyl pyrazolone 128 underwent the Gewald reaction
and reacted with sulfur and malononitrile in equimolar ratios under reflux for 3 h in the
presence of triethyl amine (TEA) and absolute ethanol as a solvent to give the amino cyano
derivative f hienopyrazol 209 (Scheme 102) [142,143].
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Scheme 102. Synthesis of amino cyano thieno[2,3-c]pyrazole 209.
Elgemeie et al. [144] reported the synthesis of thieno[3,4-c]pyrazole ring system 212
(Scheme 103). Preparation of 212 started through the reaction of pyrazolin-5-one 128 re-
acted carbon disulfide in the presence of sodium ethoxide to afford the sodium dithiolate
210. Then, one equivalent of phenacyl bromide was added to 210 to give the correspond-
ing sodium salt of monoalkylated product 211. Finally, compound 211 was cyclized to
afford the thienopyrazole-4-thiol 212 upon refluxing with sodium ethoxide, followed by
acidification (Scheme 103) [144].
El-Saraf et al. [145] prepared a series of thieno[3,4-c]pyrazoles via reacti n of the 3-
minopyrazolin-5-one 213 with CS2 and different molar ratios of various halo compounds
having active methylene under phase transfer condition (PTC), which afforded compounds
214–217 (Scheme 104) [145].
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Scheme 104. Synthesis of thieno[3,4-c]pyrazoles 214–217.
3.2.3. Furopyrazole
Furopyrazoles are known to have antitumor, antiproliferative, and antimicrobial activ-
ities. Aziz et al. observed that equimolecular amounts of 3-methyl-4-bromo-2-pyrazolin-
5-one (197) and malononitrile reacted in absolute ethanol in the presence of piperidine
under reflux for 3 h to give furo[2,3-c]pyrazole 218 n 85% yield (Scheme 105) [146]. Then
compound 197 reacted with ethyl cyanoacetate to give furo[2,3-c]pyrazole 219 in 80% yield.
Whereas benzoylacetonitrile reacted with compound 197 to afford furo[2,3-c]pyrazole 220
in 83% yield (Scheme 105) [147].
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Scheme 106. Synthesis of N-phenyl furo[2,3-c]pyrazole 218.
Rh2(OAc)4 was used as a catalyst of [3 + 2]cycloaddition reaction between 4-
diazo-1-phenyl-3-(trifluoromethyl)-1H-pyrazol-5(4H)-one 221 and aromatic alkynes 20
( eme 107) [149].
I 2019, Milišiūnaitė et al. [150] reported that the synthesis of 2H-furo[2,3-c]pyrazoles 224
was achieved 5-endo-dig cyclization to afford 4-alkynyl-3-hydroxy-1-phenyl-1H-pyrazoles
223 as a key step and catalyzed by AgOTf/K2CO3. The reactions were complete in DMF at
120 ◦C after 14 h, and the products 224 were obtained in 64–85% yields (Scheme 108) [150].
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Scheme 109. Synthesis of dihydrospirofuro[2,3-c]pyrazoles 225.
4,5-Dihydro-1H-furo[2,3-c]pyrazole derivatives 226 were synthesized by a one-pot
domino reaction involving pyrazolone 128, aromatic aldehydes 34, and a pyridinium salt
catalyzed by DABCO with high diastereoselectivity in H2O under microwave irradiation
(S eme 110) [152].
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antiproliferative EGFR-TK inhibition activity against many tumor cell lines. Moreover, a 
series of pyrazole/quinolones 61a–f (Figure 10) showed remarkable anticancer activities 
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4. Biological Activities
4.1. Anticancer Activity
It was previously mentioned by Aly et al. (see Scheme 23) [60] that 5-amino-1-(1-
ethyl-2-oxo-1,2-dihydroquinolin-4-yl)-1H-pyrazole-3,4-dicarbonitrile 56 showed a good
antiproliferative EGFR-TK inhibition activity against many tumor cell lines. Moreover,
a series of yrazole/quinolon s 61a–f (Figure 10) showed remarkable anticancer activi-
ties [61]. Compounds 61a, 61c, and 61f showed a significant decrease in inflammatory
mediators TNFα and CRB greater than NAC when compared to model group exhibited a
significant decr ase in compariso to NAC, espe ially compound 61c whose fo nd CRB
conc 1.90 (mg/dL) in comparison to NAC of conc 2.13 mg/dL.
In 2016, Wu, P.; reported that 5-((4-((2,3-dimethyl-2H-indazol-6- yl)(methyl)amino)
pyrimidin-2-yl)amino)-2-methylbenzene-sulfonamide (Figure 10, 229) as molecule kinase
inhibitor [154].
Galunisertib (Figure 10) is known as 6-quinoline carboxamide of pyrazole derivative
230 [155], and it is an oral drug that is described as an available, small molecule antagonist
of the tyrosine kinase transforming growth factor-beta (TGF-β) receptor type 1 (TGFBR1),
with potential antineoplastic activity.
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Another pyrazolo-anticancer drug known as Lorlatinib 231 (Figure 10) [156] is an
orally available drug known as ATP-competitive inhibitor of the receptor tyrosine kinases,
anaplastic lymphoma kinase (ALK), and C-ros oncogene 1 (Ros1), with potential anti-
neoplastic activity. Lorlatinib binds to and inhibits both ALK and ROS1 kinases. The
kinase inhibition leads to disruption of ALK- and ROS1-mediated signaling and eventually
inhibits tumor cell growth in ALK- and ROS1-overexpressing tumor cells.
Al-Saadi et al. [157] synthesized a series of pyrazole and pyrazoline 232 fused ring sys-
tems substituted with anticancer biologically active chemical species. Lv et al. [158] synthe-
sized a series of pyrazole-1-carbothioamide derivatives that showed high antiproliferative
activity against MCF-7 with IC50 0.08 µM. Among them, compound 3-(3,4-dimethylphenyl)-
5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazole-1-carbothioamide 233 is most potent with
IC50 of 0.07 µM, as compared to positive control erlotinib (IC50 of 0.03 µM) [158].
The anticancer activity of several thiazolone-based compounds containing the 5-aryl-3-
phenyl-4,5-dihydro-1H-pyrazol-1-yl 234 was examined by Havrylyuk et al. (Figure 10) [159].
Whereas Zheng et al. synthesized a series of 3-aryl-1-(4-tert-butylbenzyl)-1H-pyrazole-5-
carbohydrazidehydrazone derivatives and investigated their effects on A549 cell growth,
the compound (E)-2-(1-(2-((1-(4-(tert-butyl)benzyl)-3-(4-chlorophenyl)-1H-pyrazol-5-yl)
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methyl)hydrazono)ethyl)-4-chlorophenol 235 (Figure 10) showed high growth inhibitory
effect and induced apoptosis of A549 lung cancer cells [160]. On the other hand, Ka-
mal et al. reported the synthesis of oxindole–pyrazole derivatives as potent microtubules
binders/anticancer agents. Among all, compound 236 (Figure 10) showed anti-proliferative
agents with average IC50 = 3 µM against HeLa, A549, MCF7, and DU145 cancer cell lines
compared to the reference drug nocodazole with average IC50 = 1.72 µM [161].
Inhibitor 238 was synthesized by McElroy et al. [162]. The reaction of the pyra-
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Palaska et al. reported on synthesizing several N1-thiocarbamoyl-3,5-diaryl- 4,5-di-
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Scheme 112. Synthesis of pyrazole IRAK4 inhibitor 238.
Lim et al. reported on synthesizing a series of 5-amino-N-(1H-pyrazol-4-yl)-pyrazolo-
[1,5-a]pyrimidine-3-carboxamides 239 and 240 as IRAK4 inhibitors.
Different substituents of 239 and 240 led to identifying IRAK4 inhibitors with excel-
lent potency, kinase selectivity, and pharmacokinetic properties suitable for oral dosing
(Figure 11) [163].
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Ö zdemir et al. prepared several series of 1-(4-aryl-2-thiazolyl)-3- (2-thienyl)-5-aryl-2-
pyrazoline derivatives 243 (Figure 13) and screened them for antimicrobial activities 
against, e.g., Escherichia coli, Staphylococcus aureus, Salmonella typhimurium, Bacillus cereus, 
Streptococcus faecalis, Aeromonas hydrophila, Candida albicans, and Candida glabrata [166]. 
Zampieri et al. synthesized several 1-(3,5-diaryl-4,5-dihydropyrazol-4-yl)-1H–imid-
azole derivatives 244 (Figure 13) and tested for their in vitro antifungal and antimycobac-
terial activities. These imidazole derivatives showed excellent antifungal activity against 
the clinical strain of C. albicans [167]. 
Akbas et al. prepared 4-benzoyl-1-methyl-5-phenyl-N-(phenylcarbamoyl)-1H-pyra-
zole-3-carboxamide (245) activity against Bacillus cereus, Staphylococcus aureus, Escherichia 
coli, and Pseudomonas putida. The results showed that compound 245 (Figure 13) exhibits 
good antibacterial activity against Gram-positive and Gram-negative bacteria [168]. A se-
ries of 5-amido-1-(2,4-dinitrophenyl)-1H-pyrazole-4-carbonitriles was reported by 
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4.3. Antimicrobial and Antifungal Activity
5–Aryl-isonicotio yl-3-(pyridine-2-yl)-4,5–dihydro-1H-pyrazoles 242 (Figure 13) were
synthesized and showed significant antimycobacterial activity [165].
Özdemir et al. prepared several series of 1-(4-aryl-2-thiazolyl)-3- (2-thienyl)-5-aryl-
2-pyrazoline derivatives 243 (Figure 13) and screened them for antimicrobial activities
against, e.g., Escherichia coli, Staphylococcus aureus, Salmonella typhimurium, Bacillus cereus,
Streptococcus faecalis, Aeromonas hydrophila, Candida albicans, and Candida glabrata [166].
Zampieri et al. synthesized several 1-(3,5-diaryl-4,5-dihydropyrazol-4-yl)-1H–imidazole
derivatives 244 (Figure 13) and tested for their in vitro antifungal and antimycobacterial
activities. These imidazole derivatives showed excellent antifungal activity against the
clinical strain of C. albicans [167].
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Akbas et al. prepared 4-benzoyl-1-methyl-5-phenyl-N-(phenylcarbamoyl)-1H-pyrazole-
3-carboxamide (245) activity against Bacillus cereus, Staphylococcus aureus, Escherichia coli,
and Pseudomonas putida. The results showed that compound 245 (Figure 13) exhibits good
antibacterial activity against Gram-positive and Gram-negative bacteria [168]. A series of
5-amido-1-(2,4-dinitrophenyl)-1H-pyrazole-4-carbonitriles was reported by Rahimizadeh
et al., showing that compound 246 exhibited antimicrobial activities against methicillin-
susceptible, Staphylococcus aureus (MSSA , and methicillin-r sistant Staphylococcus aureus
(MRSA), w th MIC values of 25.1 µM [169].
A seri s of pyrazole derivatives were synthesized and screened as antibacterial agents
against Staphylococcus aureus, Bacillus subtilis, Escherichia coli, and Pseudomonas aeruginosa.
Among the tested compounds, 247–250 (Figure 14) indicated excellent antibacterial activity
against all the tested bacterial strains as compared with the standard drug ceftriaxone,
which was active at 3.125, 1.6125, 1.6125, and 1.6125 µg/mL against Staphylococcus au-
reus, Bacillus subtilis, Escherichia coli, and Pseudomonas aeruginosa strains, respectively
(Figure 14) [170].
Compound 251 inhibits activity against both Gram-positive and Gram-negative bacte-
ria [171]. In addition, pyrazole derivatives 252–253 (Figure 14) were prepared and screened
for their antibacterial and antifungal activities using ampicillin and norcadine as standard
drugs. All compounds were screened for their antimicrobial activities [172].
3-(4-Chlorophenyl)-5-((1-phenyl-3-aryl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-
4-ones were prepared by B’Bhatt and Sharma. Compound 254 (Figure 14), as a derivative of
the last series, was found to show potent activity against Escherichia coli, while compound
255 (Figure 14) was found to be potent against S. aureus, S. pyogenes, and was found to
have very good activity against Candida albicans [173].
In 2020, Alnufaie et al. reported on the synthesis of series of naphthyl-substituted
pyrazole-derived hydrazones 260 [174].
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Reaction of 4-hydrazinobenzoic acid (256) with 2-acetylnaphthalene (257) afforded
the corresponding condensed product 258, which on Vilsmeier–Haack reagent gave com-
pound 259. Finally reaction of 259 with hydrazine derivatives produced the corresponding
pyrazoles 260 (Scheme 113) [174]. Many of these pyrazoles showed potent growth in-
hibitory properties for planktonic Staphylococcus aureus and Acinetobacter baumannii, and
its drug-resistant variants with MIC values as low as 0.78 and 1.56 µg/mL, respectively.
These compounds also show potent activity against Staphylococcus aureus and Acinetobacter
baumannii biofilm formation and eradication properties [174].
Similarly, the same group published on the synthesis and antimicrobial studies of 31
coumarin-substituted pyrazole derivatives 264 [175]. The reaction of 4-hydrazinobenzoic
acid 256 with fluoro 261a and hydroxy 261b substituted 3-acetylcoumarin formed the cor-
responding hydrazones 262a,b, which were subjected to further reaction with POCl3/DMF
to give the formyl-substituted pyrazole derivatives 363a,b (Scheme 114). A series of hy-
drazone derivatives were then obtained via the reaction of 263a,b with various hydrazine
derivatives (Scheme 114) [175]. Some of these compounds have shown potent activity
against methicillin-resistant Staphylococcus aureus (MRSA) with MIC as low as 3.125 µg/mL.
These results are very significant, as MRSA strains have emerged as one of the most men-
acing pathogens of humans, and this bacterium is bypassing HIV (in terms of fatality
rate). Some pyrazole derivatives inhibited the growth of cell lines with an IC50 around
15 µg/mL [175].
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loxacin and clotrimazole were used as standard drugs [46]. 
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Bondock et al. reported on the synthesis of groups of pyrazole-pyrimidine deriva-
tives. One of them, N-(benzo[d]thiazol-2-yl)-7-methyl-2-(phenylamino)pyrazolo-[1,5-
a]pyrimidine-3-carboxamide 265, was found to exhibit the most potent in vitro antifungal 
activity with MICs (6.25 μ/mL) against A. fumigatus and F. Oxysporum, comparable with 
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4.4. Anti-Inflammatory Activity 
Kendre et al. reported some 1H-pyrazole derivatives containing aryl sulfonate moie-
ties 266 with anti-inflammatory effects (Figure 16) [177]. 
Scheme 114. Synthesis of antibacterial pyrazole derivatives 264.
Sahu et al. also prepared 4-((5-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl)amino)
phenol (18) (Figure 15), which showed antimicrobial activity and antibacterial activity.
Antifungal activity was tested on Sabouraud Dextrose Agar plates by the cup–plate method
against Ca dida albicans and Aspergillus niger. In both of these assays, ciprofloxacin and
clotrimazole were used as standard drugs [46].
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Bondock et al. reported on the synthesis of groups of pyrazole-pyrimidine derivatives.
One of them, N-(benzo[d]thiazol-2-yl)-7-methyl-2-(phenylamino)pyrazolo-[1,5-a]pyrimidine-
3-carboxamide 265, was found to exhibit the most potent in vitro antifungal activity with
MICs (6.25 µ/mL) against A. fumigatus and F. Oxysporum, comparable with cycloheximide
(3.125 µ/mL) [176].
4.4. Anti-Inflammatory Activity
Kendre et al. reported some 1H-pyrazole derivatives containing aryl sulfonate moieties
266 with anti-infla matory effects (Figure 16) [177].




Figure 16. Structures of anti-inflammatory pyrazoles 266–269. 
Tewari et al. prepared pyrazole derivatives 267–269, and their anti-inflammatory ac-
tivities were screened using carrageenan rat paw edema bioassay. Among the reported 
compounds, 268b showed maximum COX-2 inhibitory potency (IC50 = 0.44) µM), while 
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3,6-Disubstituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles bearing pyrazole moieties 
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compounds, compound 270g showed the most significant anti-inflammatory activity 
(64.7% inhibition) compared to the standard drug diclofenac sodium (80.4% inhibition), 
whereas compounds 270d and 270f showed 56.9% inhibition. The propyl and p-chloro-
phenyl substituents of 270b and 270f showed significant activity. Whereas compounds 
have ethyl and p-chlorophenyl moieties, 270a and 270c accounted for moderate activities 
[179]. 
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Tewari et al. prepared pyrazole derivatives 267–269, and their anti-inflammatory
activities were screened using car geenan rat paw edema bioassay. Among the reported
compounds, 268b showed maximum COX-2 inhibitory potency (IC50 = 0.44) µM), w ile
compounds 269a and 269b showed inter ediate effects. (Figure 16) [178].
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3,6-Disubstituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles bearing pyrazole moieties
270a–g (Figure 17) were screened as anti-inflammatory agents [179]. Among the reported
compounds, compound 270g showed the most significant anti-inflammatory activity (64.7%
inhibition) compared to the standard drug diclofenac sodium (80.4% inhibition), whereas
compounds 270d and 270f showed 56.9% inhibition. The propyl and p-chlorophenyl
substituents of 270b and 270f showed significant activity. Whereas compounds have ethyl
and p-chlorophenyl moieties, 270a and 270c accounted for moderate activities [179].
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El-Sayed et al. also synthesized pyrazole derivatives 271 and 272 (Figure 17), and their
anti-inflammatory activities were screened. Compounds 271a and 271d were found as the
most selective among the tested compounds with good inhibitory profiles against COX-2
(Figure 17) [180].
4.5. Antiviral Activity
It was reported that the derivative containing the R = Cl group of a series of 4,5-
disubstituted pyrazole derivatives 273 (Figure 18) showed broad potent antiviral activity
against a broad panel of viruses in different cells cultures (HEL Cell cultures) [181]. More-
over, substituted pyrazole derivatives 274 (Figure 18) showed good antiviral activity against
hepatitis A [182].
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4.6. Anti-Alzheimer’s Activity
A series of 3,5-diaryl pyrazoles 5 (Figure 19) was assayed for their ability to inhibit
monoamine oxidase-A (MAO-A) and monoamine oxidase B (MAO-b) reversibly. Sev-
eral compounds show inhibitory activity with concentration values in the nanomolar
range [183]. Kuduk et al. identified compound 275 (Figure 19) as a potent and selective
full agonist of the M1 positive allosteric modulators [184]. In the same manner, compound
275 showed good inhibitory activity against MAO-A and MAO-B but low selectivity (IC50
MAO-A = 9.00 nM, IC50 MAO-B = 8.00 nM, and SI = 1.00).
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Interestingly, it was reported that treatment of Cognitive impairment associated with 
Alzheimer’s disease (AD) and schizophrenia was associated with α7 nicotinic acetylcho-
line receptor (α7nAChR) that represented promising therapeutic candidates [190]. As 
compound 282 (Figure 20) was found, a potent and selective full agonist of the α7 nAChR 
demonstrated improved plasma stability, brain levels, and efficacy in behavioral cogni-
tion models. 
On the other side, it was demonstrated that pyrazole 283 proved to be a potent and 
selective fair pharmacokinetic profile accompanied by efficacy in rodent behavioral cog-
nition models. Compound 284 (Figure 20) was investigated and found as the most potent 
inhibitor of α7 nAChR with an IC50 value of 0.07 µM [191]. Astra Zeneca AB developed 
diverse series of pyrazole derivatives as positive allosteric modulators (PAMs). 
Compound 285 (Figure 20) expressed good activity by inhibiting nicotinic acetylcho-
line receptors (nAChRs) [192]. The trisubstituted pyrazole 286 (Figure 20) showed unusual 
activity with a PEC50 value of 7.11 (62.68% efficacy) and a PAM type 4 profile [193]. 
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A group of pyrazolyl and thienyl aminohydatoins was prepared by Malamas et al.
and wa tested as potent BACE1 inhibito s [185]. The n-butyl analog 276 was the most
potent analog, with an IC50 value of 8 nM.
Zou et al. reported on the synthesis of a series of pyrazole-based compound 277
(Figure 19) and identified as C-terminus β-secretase 1 (BACE1) inhibitors [186]. Further,
modification over the pyrazole scaffold leads to the identification of compound 278 as a
potent inhibitor of BACE1 with an IC50 value of 0.025 µM.
Results reported by Han et al. indicated that the most active analogs 279 (Figure 19)
exhibited higher inhibitory activities, with significant brain A β-lowering effects, as well as
favorable aqueous solubility [187].
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As acetylcholinesterase (AChE) inhibitors, pyrazolotacrines 280 (Figure 20) were
reported by Silva et al. The results showed that compound 280 was the most potent
inhibitor of AChE, which inhibited the enzyme above with an IC50 value of 0.069 µM [188].
Whereas Khoobi et al. synthesized compound 281 bearing 3,4-dimethoxyphenyl group was
the most potent compound against acetylcholinesterase (AChE) [189], being more active
than the reference drug tacrine.
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Interestingly, it was reported that treatment of Cognitive impairment associated with
Alzheimer’s disease (AD) and schizophrenia was associated with α7 nicotinic acetylcholine
receptor (α7nAChR) that represented promising therapeutic candidates [190]. As com-
pound 282 (Figure 20) was found, a potent and selective f ll agonist of the α7 nAChR
demonstrated i proved plasma stability, brain levels, an effic cy in ehavioral cogni-
tion models.
On the other side, it was demonstrated that pyrazole 283 proved to be a potent
and selective fair pharmacokinetic profile accompanied by efficacy in rodent behavioral
cognition models. Compound 284 (Figure 20) was investigated and found as the most
potent inhibitor of α7 nAChR with an IC50 value of 0.07 µM [191]. Astra Zeneca AB
developed diverse series of pyrazole derivatives as positive allosteric modulators (PAMs).
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Compound 285 (Figure 20) expressed good activity by inhibiting nicotinic acetyl-
choline receptors (nAChRs) [192]. The trisubstituted pyrazole 286 (Figure 20) showed
unusual activity with a PEC50 value of 7.11 (62.68% efficacy) and a PAM type 4 profile [193].
4.7. Insecticides and Herbicides
Synthesized pyrazoline-type insecticides 287 (Figure 21) were achieved and examined
the mechanism of action of these compounds based on available electrophysiological,
pharmacological, and toxicological information, and they were found to act at neuronal
target sites [194].
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The hypotensive activity of the synthesized 1-(4-arylthiazol-2-yl)-3,5-diaryl-2-pyra-
zoline derivatives 293a,b (Figure 23) [198] and the compounds were investigated by a tail-
cuff method using clonidine as a reference standard. The obtained compounds showed 
appreciable hypotensive activities. 
 
Figure 23. Structures of some pyrazoles 293a,b of Hypotensive activity. 
4.10. Anti-HIV 
Charles and coworkers constructed 3-cyanophenoxypyrazoles 294 (Figure 24) and 
investigated it in vitro against HIV. The compounds illustrated excellent anti-HIV affinity 
with inhibition of wild type RT (IC50= 0.034–0.6 µM) [199]. 
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Anti-depressant potency pyrazoles 290–292 (Figure 22) showed using tail suspen-
sion behavioral despair test and anti-convulsant potency against pentylenetetrazol (PTZ)-
induced seizures in mice [197]
4.9. Pyrazole as Hypote sive Agents
The hypotensive activity of the synthesized 1-(4-arylthiazol-2-yl)-3,5-diaryl-2-pyrazoline
derivatives 293a,b (Figure 23) [198] and the compounds were investigated by a tail-cuff
method using clonidine as a reference standard. The obtained compounds showed appre-
ciable hypotensive activities.
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4.11. Hypoglycemic
1,5-Diaryl pyrazole derivatives 295–297 (Figure 25) were synthesized, and the com-
pounds were investigated the biological activity in metabolic disorders, and their hypo-
glycemic activity in an in vivo model were tested. Interestingly, a high degree of correlation
was observed between the predicted pKi and hypoglycemic effect after administration.
Compounds 295–297 showed significant plasma glucose reduction with decreases of 60%,
64%, and 60%, respectively [200].
4.12. Anti-Oxidant Activity
In 2021, Vagish C. B. et al. [201] reported that the synthesized compounds 298
(Figure 26), which revealed modest to good antioxidant activities. The synthesized pyra-
zoles, 298, were screened for their antioxidant activity by in vitro DPPH and hydroxyl
radical scavenging activity. Assessment result showed that compounds 3-(4-chlorophenyl)-
5-(2,4-dichlorophenyl)-1-phenyl-4,5-dihydro-1H-pyrazole 298a revealed % radical scaveng-
ing activity
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(% I) (20.76–45.14% and 19.46–43.56%), while, 1-(3-chlorophenyl)-3-(4-chlorophenyl)-
5-(2,4-dichlorophenyl)-4,5-di dro-1H-pyrazole (298b) showed (23.91–46.16% and 20.46–
45.07%). Moreover, 1-(3-chlorophenyl)-5-(2,4-dichlorophenyl)-3-(2-methoxyphenyl)-4,5-
dihydro-1H-pyrazole (298c) showed (22.50–42.48% and 20.55–42.80%) show the excellent
activities in both DPPH and hydroxyl radical scavenging assay comparable with ascorbic
acid and BHA, even with the reported structurally related compounds.
Mantzanidou et al. [202] evaluated the antioxidant activity of pyrazole derivatives
5a and 299a. Compounds 5a and 299a were found as the most lipophilic compounds and
showed antioxidant activity using the ABTS radical cation (ABTS+) generated through
potassium persulfat by oxid tion with no participation of an interm diary radical. The
synthesis of the pyrazolines and pyrazole derivatives was accomplished via the conden-
sation of substituted suitable chalcones and hydrazine hydrate in absolute ethanol in the
presence of drops of glacial acetic acid, as presented in Scheme 115 [202].
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5. Conclusions
There is a growing body of evidence that pyrazole and its heteroannulated derivatives
provide a viable and valuable area for drug discovery. Here, we illustrated an overview of
the many efficient, mild, operationally simple, and non-conventio al synt etic methods
to access a library of highly functionalized pyrazole together with their heteroannulated
derivatives. We also shed more light on the broad range of biological activities displayed
by these scaffolds that can optimally present a way to capture their intrinsic values. The
ability to predict drug-like and lead-like properties along with recent technological ad-
vances could be sufficient to revitalize the exploitation of the value of pyrazoles and their
heteroannulated derivatives in the quest for new drugs.
Previous studies have shown that the structural modification on the different positions
of th basic molecule allows for improving its pharmacological profile, giving it antimicro-
bial, anticonvulsant, analgesic, anti-inflammatory, anti-viral, anti-malarial, and anti-cancer
properties. Recently, researchers have established the design of more potent pyrazole
derivatives having a great diversity of biological activity. Afterward, they synthesized the
prospective biologically active classes nd finally screened the synthesized compounds
towards the aim and type of biological activity.
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